BIOA – bioage labs, inc. (US:NASDAQ)
Stock Stats
News
BioAge Labs (NASDAQ:BIOA) was given a new $23.00 price target on by analysts at Morgan Stanley.
BioAge Labs (NASDAQ:BIOA) was upgraded by analysts at Wall Street Zen
BioAge Labs (NASDAQ:BIOA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
BioAge Labs (NASDAQ:BIOA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)
Form 4 BioAge Labs, Inc. For: Feb 02 Filed by: RUBIN PAUL D
Form 4 BioAge Labs, Inc. For: Feb 01 Filed by: GOLDSTEIN DOV A MD
Form 144 BioAge Labs, Inc. Filed by: RUBIN PAUL D
Form 8-K BioAge Labs, Inc. For: Jan 21
Form 424B5 BioAge Labs, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.